WINTON GROUP Ltd Makes New $2.47 Million Investment in Axon Enterprise, Inc $AXON

WINTON GROUP Ltd bought a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 4,409 shares of the biotechnology company’s stock, valued at approximately $2,472,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. California State Teachers Retirement System raised its position in shares of Axon Enterprise by 55,955.7% in the second quarter. California State Teachers Retirement System now owns 64,781,849 shares of the biotechnology company’s stock valued at $36,317,352,000 after purchasing an additional 64,666,282 shares during the period. Edgewood Management LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth $846,516,000. Nykredit A S bought a new stake in shares of Axon Enterprise during the 2nd quarter worth $698,937,000. Wellington Management Group LLP grew its stake in Axon Enterprise by 326.9% in the 4th quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock valued at $874,463,000 after buying an additional 1,179,038 shares during the last quarter. Finally, Norges Bank acquired a new position in Axon Enterprise in the 4th quarter valued at $515,764,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the topic of several recent analyst reports. Barclays boosted their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Needham & Company LLC reissued a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, September 2nd. Finally, The Goldman Sachs Group restated a “buy” rating and set a $715.00 target price on shares of Axon Enterprise in a research note on Thursday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $721.57.

Axon Enterprise Stock Up 0.1%

Shares of AXON opened at $479.34 on Friday. The company has a 50-day simple moving average of $561.67 and a 200-day simple moving average of $488.36. The firm has a market capitalization of $38.94 billion, a P/E ratio of 198.90, a P/E/G ratio of 9.01 and a beta of 1.40. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $792.16.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. During the same quarter last year, the company earned $2.12 earnings per share. The firm’s revenue was up 35.3% on a year-over-year basis. On average, equities research analysts expect that Axon Enterprise, Inc will post 2.12 earnings per share for the current year.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey Kunins sold 9,605 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares in the company, valued at approximately $61,266,818.70. This trade represents a 8.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 66,380 shares of company stock worth $37,672,266. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.

The company also provides cloud-based software for managing digital evidence, conducting investigations, overseeing records and workflows, coordinating dispatch and supporting real-time public safety operations.